RecruitingPhase 4NCT05305287

Quantifying Hepatic Mitochondrial Fluxes in Humans

Studying Mitochondrial disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The University of Texas Health Science Center at San Antonio
Principal Investigator
Luke Norton, PhD
The University of Texas Health Science Center at San Antonio
Intervention
Pioglitazone(drug)
Enrollment
60 enrolled
Eligibility
18-80 years · All sexes
Timeline
2022 – 2027

Study locations (2)

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05305287 on ClinicalTrials.gov

Other trials for Mitochondrial disease

Additional recruiting or active studies for the same condition.

See all trials for Mitochondrial disease →

← Back to all trials